Adoptive T cell therapy with CAR modified T cells: We have a Model A Ford, can we build a Ferrari?

被引：0
|
作者：
Brentjens, Renier [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.HEMMAL14-IA17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA17
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Shiny Objects-Why We Spend Money We Don't Have in Search of Happiness We Can't Buy
    Kruger, Stefan
    APPLIED RESEARCH IN QUALITY OF LIFE, 2013, 8 (01) : 113 - 115
  • [42] Are we there yet? CAR-T therapy in multiple myeloma
    Mirvis, Eitan
    Benjamin, Reuben
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2175 - 2189
  • [43] Integrating CAR-T cell therapy into the management of DLBCL: what we are learning
    Martino, Massimo
    Canale, Filippo Antonio
    Porto, Gaetana
    Verduci, Chiara
    Utano, Giovanna
    Policastro, Giorgia
    Germano, Jessyca
    Alati, Caterina
    Santoro, Ludovica
    Imbalzano, Lucrezia
    Pitea, Martina
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (12) : 1277 - 1285
  • [44] Why We Can't Have Our Facts Back
    Marres, Noortje
    ENGAGING SCIENCE TECHNOLOGY AND SOCIETY, 2018, 4 : 423 - 443
  • [45] Vision 2030: Why can't we have it too?
    Anon
    Indian Concrete Journal, 2001, 75 (09): : 547 - 548
  • [46] Dermal γδ T cells - What have we learned?
    O'Brien, Rebecca L.
    Born, Willi K.
    CELLULAR IMMUNOLOGY, 2015, 296 (01) : 62 - 69
  • [47] Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors
    Zhang, Gui-Zhen
    Li, Tian-Fang
    Han, Shuang-Yin
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (05) : 1213 - 1220
  • [48] CAR-T cells-Real-time experience applying CAR-T cells-What we have learned so far
    Greinix, Hildegard
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (03) : 173 - 175
  • [49] Trustworthy Software: Why we need it, Why we don't have it, How we can get it
    McLean, John
    30th Annual International Computer Software and Applications Conference, Vol 1, Regular Papers/Panels, Proceedings, 2006, : 32 - 33
  • [50] Engineered T Cells: CAR T Cell Therapy and Beyond
    P. Connor Johnson
    Jeremy S. Abramson
    Current Oncology Reports, 2022, 24 : 23 - 31
12345